News & Updates

Polypill cuts risk of cardiovascular disease but not mortality

28 May 2022

Use of a fixed-dose combination therapy or a polypill effectively lowers cardiovascular risk factors but falls short of producing significant reductions in mortality, according to a systematic review and meta-analysis.

Polypill cuts risk of cardiovascular disease but not mortality

28 May 2022

Polypharmacy, wrong prescriptions persist in older cancer patients on immunotherapy

28 May 2022

Inappropriate prescription practices and polypharmacy remain a burden in patients treated with immune checkpoint inhibitors (ICIs), a study has found.

Polypharmacy, wrong prescriptions persist in older cancer patients on immunotherapy

28 May 2022

Medications to lower urate levels effective in CKD patients

28 May 2022

All urate-lowering therapies work to reduce uric acid concentrations in patients with chronic kidney disease (CKD), although it is unclear whether this benefit extends to those with renal disease, according to the results of a meta-analysis.

Medications to lower urate levels effective in CKD patients

28 May 2022

Lebrikizumab reduces asthma exacerbation in adolescents

28 May 2022 by

Treatment with either high- or low-dose lebrikizumab reduces the rate of exacerbation in patients with uncontrolled asthma, according to the ACOUSTICS* trial presented at ATS 2022.

Lebrikizumab reduces asthma exacerbation in adolescents

28 May 2022

Pharmaceutical staff exposed to antineoplastic drug contamination risk

27 May 2022

Pharmaceutical workers who serve in healthcare settings are in danger of antineoplastic drug contamination not just inside the compounding room but also in adjacent rooms, reveals a study.

Pharmaceutical staff exposed to antineoplastic drug contamination risk

27 May 2022

COVID-19 jabs help reduce long-term symptoms

27 May 2022 by

COVID-19 vaccination appears to reduce the odds of long COVID symptoms, with continuous improvement following a second dose, at least in the first few months after the shot, suggests a study.

COVID-19 jabs help reduce long-term symptoms

27 May 2022

Linzagolix benefits Hb levels, mood, QoL

26 May 2022 by

The use of the oral GnRH antagonist linzagolix in patients with heavy menstrual bleeding (HMB) due to uterine fibroids induced multiple benefits including improved haemoglobin (Hb) levels, health-related quality of life (HRQoL), and mood, analysis of the PRIMROSE 1 and 2 trials showed.

Linzagolix benefits Hb levels, mood, QoL

26 May 2022

Meta-analysis proves value of fostemsavir in multidrug-resistant HIV-1

26 May 2022 by

The first-in-class attachment inhibitor fostemsavir, when combined with optimized background therapy (OBT), provides an important treatment option for heavily treated HIV-1 patients with multidrug resistance and limited available antiretroviral (ARV) options, a matching adjusted indirect comparison (MAIC) analysis has shown.

Meta-analysis proves value of fostemsavir in multidrug-resistant HIV-1

26 May 2022

Insufficient antibiotic regimen leads to more complications in paediatric appendectomy

26 May 2022 by

In paediatric patients undergoing appendectomy, an insufficient antibiotic regimen may result in longer length of stay (LOS) and more infectious complications, which validates the expansion of a simple antibiotic regimen in cases of severe intra-abdominal findings, a study has shown. In uncomplicated cases of appendicitis, treatment with ampicillin-sulbactam (AS) is suggested.

Insufficient antibiotic regimen leads to more complications in paediatric appendectomy

26 May 2022

Long COVID: What factors contribute to the risk?

25 May 2022 by

Only a minority of patients are considered fully recovered 1 year after being discharged from hospital due to COVID-19, with women and obese individuals at increased risk of long COVID, according to results of the prospective PHOSP-COVID* study presented at ECCMID 2022 and published in The Lancet.

Long COVID: What factors contribute to the risk?

25 May 2022

News & Updates

Filter by Specialty:

Specialty:

Polypill cuts risk of cardiovascular disease but not mortality

Polypill cuts risk of cardiovascular disease but not mortality

Polypharmacy, wrong prescriptions persist in older cancer patients on immunotherapy

Polypharmacy, wrong prescriptions persist in older cancer patients on immunotherapy

Medications to lower urate levels effective in CKD patients

Medications to lower urate levels effective in CKD patients

Lebrikizumab reduces asthma exacerbation in adolescents

Lebrikizumab reduces asthma exacerbation in adolescents

Pharmaceutical staff exposed to antineoplastic drug contamination risk

Pharmaceutical staff exposed to antineoplastic drug contamination risk

COVID-19 jabs help reduce long-term symptoms

COVID-19 jabs help reduce long-term symptoms

Linzagolix benefits Hb levels, mood, QoL

Linzagolix benefits Hb levels, mood, QoL

Meta-analysis proves value of fostemsavir in multidrug-resistant HIV-1

Meta-analysis proves value of fostemsavir in multidrug-resistant HIV-1

Insufficient antibiotic regimen leads to more complications in paediatric appendectomy

Insufficient antibiotic regimen leads to more complications in paediatric appendectomy

Long COVID: What factors contribute to the risk?

Long COVID: What factors contribute to the risk?